Oaktree Fund Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-66,000
| Closed | -$23.8K | – | 49 |
|
|
2023
Q1 | $23.8K | Hold |
66,000
| – | – | 0.02% | 38 |
|
|
2022
Q4 | $58.5K | Hold |
66,000
| – | – | 0.09% | 16 |
|
|
2022
Q3 | $103K | Hold |
66,000
| – | – | 0.16% | 15 |
|
|
2022
Q2 | $132K | Buy |
66,000
+16,000
| +32% | +$32K | 0.23% | 14 |
|
|
2022
Q1 | $116K | Hold |
50,000
| – | – | 0.19% | 14 |
|
|
2021
Q4 | $232K | Sell |
50,000
-16,000
| -24% | -$74.2K | 0.48% | 13 |
|
|
2021
Q3 | $503K | Hold |
66,000
| – | – | 48.93% | 1 |
|
|
2021
Q2 | $640K | Buy |
+66,000
| New | +$640K | 60.89% | 1 |
|